|
Volumn 12, Issue 7, 2009, Pages 434-439
|
HIV vaccine development: Lessons from the past, informing the future
|
Author keywords
ELISPOT; HIV; HIV vaccine; Neutralizing antibody; Nonhuman primate model; Simian immuno deficiency virus; SIV; T cell vaccine
|
Indexed keywords
CD4 ANTIGEN;
CD8 ANTIGEN;
GAMMA INTERFERON;
HLA ANTIGEN;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
NEUTRALIZING ANTIBODY;
RECOMBINANT VACCINE;
HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;
ADENOVIRUS 5;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CELLULAR IMMUNITY;
CLINICAL RESEARCH;
CLINICAL TRIAL;
DRUG EFFICACY;
EFFECTOR CELL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
IMMUNOGENICITY;
MEMORY CELL;
NONHUMAN;
PRIMATE;
REVIEW;
SIMIAN IMMUNODEFICIENCY VIRUS;
VIRUS IMMUNITY;
VIRUS LOAD;
VIRUS NEUTRALIZATION;
ANIMAL;
BIOSYNTHESIS;
DISEASE MODEL;
DRUG DEVELOPMENT;
DRUG EFFECT;
GENETICS;
IMMUNOLOGY;
METHODOLOGY;
TREATMENT FAILURE;
AIDS VACCINES;
ANIMALS;
CD4-POSITIVE T-LYMPHOCYTES;
CD8-POSITIVE T-LYMPHOCYTES;
CLINICAL TRIALS AS TOPIC;
DISEASE MODELS, ANIMAL;
DRUG DISCOVERY;
HIV ANTIBODIES;
HIV INFECTIONS;
HIV-1;
HUMANS;
TREATMENT FAILURE;
|
EID: 68149108469
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (13)
|
References (5)
|